SCHEMBL2469102

SCHEMBL2469102

CCCCCc1ccc(CNC(=O)c2ccc(CN(C(=O)CCC3CCCC3)c3ccc(O)c(C(=O)O)c3)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 9/20 0.54
PTPN11 Q06124 1/20 0.43
PTPRO Q16827 1/20 0.43
SLC6A4 P31645 2/20 0.42
LTB4R2 Q9NPC1 1/20 0.42
KAT8 Q9H7Z6 2/20 0.42
HTR1A P08908 1/20 0.40
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
HTR7 P34969 1/20 0.40
ADRA1B P35368 1/20 0.40
DRD3 P35462 1/20 0.40
HTR2B P41595 1/20 0.40
HTR5A P47898 1/20 0.40
HTR6 P50406 1/20 0.40
PLK1 P53350 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2472477 0.94 STAT3 (0.46) STAT3SLC6A4LTB4R2PDK1
SCHEMBL2468215 0.90 KAT8 (0.47) STAT3PTPN11PTPROSLC6A4KAT8
SCHEMBL13711620 0.90 STAT3 (0.63) STAT3PTPN11PTPROLTB4R2KAT8
SCHEMBL2472681 0.87 STAT3 (0.64) STAT3PTPN11PTPROLTB4R2KAT8
SCHEMBL2466208 0.85 STAT3 (0.59) STAT3PDK1
SCHEMBL5142598 0.84 SLC6A4 (0.44) STAT3SLC6A4LTB4R2HTR1ADRD2
SCHEMBL2848964 0.84 PTPN11 (0.60) STAT3PTPN11PTPROLTB4R2KAT8
SCHEMBL5144007 0.81 STAT3 (0.44) STAT3SLC6A4LTB4R2KAT8HTR1A
SCHEMBL2470089 0.81 STAT3 (0.67) STAT3PTPN11PTPROKAT8PLK1
SCHEMBL13711669 0.79 STAT3 (0.50) STAT3SLC6A4LTB4R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US claimed
EP-1656139-A1 ARYL DICARBOXAMIDES Applied Research Systems ARS Holding N.V. (AN) 2006-05-17 EP claimed
WO-2005011685-A1 ARYL DICARBOXAMIDES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2005-02-10 WO claimed
EP-1656139-B1 ARYL DICARBOXAMIDES MERCK SERONO SA (CH) 2011-10-05 EP disclosed
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US disclosed
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US disclosed
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US disclosed
US-20060189583-A1 Aryl dicarboxamides MERCK SERONO SA (CH) 2006-08-24 US disclosed
EP-1656139-A1 ARYL DICARBOXAMIDES Applied Research Systems ARS Holding N.V. (AN) 2006-05-17 EP disclosed
WO-2005011685-A1 ARYL DICARBOXAMIDES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2005-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189583-A1 Aryl dicarboxamides GPR119, PTPRS, ECHS1 STAT3 3402/4885PTPN11 80/4885PTPRO 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.